Paying for performance to improve the delivery of health interventions in low- and middle-income countries .

PubWeight™: 2.49‹?› | Rank: Top 2%

🔗 View Article (PMID 22336833)

Published in Cochrane Database Syst Rev on February 15, 2012

Authors

Sophie Witter1, Atle Fretheim, Flora L Kessy, Anne Karin Lindahl

Author Affiliations

1: Immpact, University of Aberdeen, Aberdeen, UK. 2Global Health Unit, Norwegian Knowledge Centre for the Health Services, Oslo,Norway. sophiewitter@blueyonder.co.uk.

Articles citing this

Designing a theory-informed, contextually appropriate intervention strategy to improve delivery of paediatric services in Kenyan hospitals. Implement Sci (2013) 1.25

Performance-based financing as a health system reform: mapping the key dimensions for monitoring and evaluation. BMC Health Serv Res (2013) 1.19

Performance-based financing in low- and middle-income countries: still more questions than answers. Bull World Health Organ (2012) 1.16

Targeted interventions for improved equity in maternal and child health in low- and middle-income settings: a systematic review and meta-analysis. PLoS One (2013) 1.10

Design of an impact evaluation using a mixed methods model--an explanatory assessment of the effects of results-based financing mechanisms on maternal healthcare services in Malawi. BMC Health Serv Res (2014) 1.05

The impact of performance incentives on child health outcomes: results from a cluster randomized controlled trial in the Philippines. Health Policy Plan (2013) 1.04

Evidence from district level inputs to improve quality of care for maternal and newborn health: interventions and findings. Reprod Health (2014) 1.01

Protocol for the evaluation of a pay for performance programme in Pwani region in Tanzania: a controlled before and after study. Implement Sci (2013) 1.00

Factors associated with job satisfaction among commune health workers: implications for human resource policies. Glob Health Action (2013) 0.97

Protocol for the process evaluation of interventions combining performance-based financing with health equity in Burkina Faso. Implement Sci (2014) 0.96

Effect of Paying for Performance on Utilisation, Quality, and User Costs of Health Services in Tanzania: A Controlled Before and After Study. PLoS One (2015) 0.96

Tracking implementation and (un)intended consequences: a process evaluation of an innovative peripheral health facility financing mechanism in Kenya. Health Policy Plan (2015) 0.94

Health systems performance assessment in low-income countries: learning from international experiences. Global Health (2014) 0.92

Local stakeholders' perceptions about the introduction of performance-based financing in Benin: a case study in two health districts. Int J Health Policy Manag (2014) 0.91

Evidence for integrating eye health into primary health care in Africa: a health systems strengthening approach. BMC Health Serv Res (2013) 0.88

Compliance with quality prescribing indicators in terms of their relationship to financial incentives. Eur J Clin Pharmacol (2013) 0.85

Time for innovative dialogue on health systems research. Bull World Health Organ (2012) 0.85

Exploring the potential for using results-based financing to address non-communicable diseases in low- and middle-income countries. BMC Public Health (2013) 0.82

The effect of performance-based financing on illness, care-seeking and treatment among children: an impact evaluation in Rwanda. BMC Health Serv Res (2015) 0.82

An innovative pay-for-performance (P4P) strategy for improving malaria management in rural Kenya: protocol for a cluster randomized controlled trial. Implement Sci (2013) 0.81

A Global Perspective on Cardiovascular Disease in Vulnerable Populations. Can J Cardiol (2015) 0.81

Compliance with quality prescribing indicators linked to financial incentives: what about not incentivized indicators?: an observational study. Eur J Clin Pharmacol (2013) 0.80

Effect of pay for performance to improve quality of maternal and child care in low- and middle-income countries: a systematic review. BMC Public Health (2016) 0.80

Sources, determinants and utilization of health workers' revenues: evidence from Sierra Leone. Health Policy Plan (2016) 0.80

Mistreatment of women during childbirth in Abuja, Nigeria: a qualitative study on perceptions and experiences of women and healthcare providers. Reprod Health (2017) 0.80

Opportunities for improving the efficiency of paediatric HIV treatment programmes. AIDS (2015) 0.79

Review of performance-based incentives in community-based family planning programmes. J Fam Plann Reprod Health Care (2014) 0.79

Boosting facility deliveries with results-based financing: a mixed-methods evaluation of the government midwifery incentive scheme in Cambodia. BMC Pregnancy Childbirth (2015) 0.79

Next generation maternal health: external shocks and health-system innovations. Lancet (2016) 0.79

Using pay for performance incentives (P4P) to improve management of suspected malaria fevers in rural Kenya: a cluster randomized controlled trial. BMC Med (2015) 0.79

Pay for performance: an analysis of the context of implementation in a pilot project in Tanzania. BMC Health Serv Res (2014) 0.78

Are health workers motivated by income? Job motivation of Cambodian primary health workers implementing performance-based financing. Glob Health Action (2016) 0.78

Measuring and understanding the effects of a performance based financing scheme applied to nutrition services in Burundi-a mixed method impact evaluation design. Int J Equity Health (2016) 0.78

Does performance-based financing increase value for money in low- and middle- income countries? A systematic review. Health Econ Rev (2016) 0.78

Workforce interventions to improve access to emergency contraception pills: a systematic review of current evidence in low- and middle-income countries and recommendations for improving performance. BMC Health Serv Res (2015) 0.77

Changing health care provider performance through measurement. Soc Sci Med (2017) 0.76

Health worker preferences for performance-based payment schemes in a rural health district in Burkina Faso. Glob Health Action (2016) 0.76

Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration. Int J Equity Health (2015) 0.76

Evaluating complex health financing interventions: using mixed methods to inform further implementation of a novel PBI intervention in rural Malawi. BMC Health Serv Res (2016) 0.75

A systematic review of strategies to increase access to health services among children in low and middle income countries. BMC Health Serv Res (2017) 0.75

Is it all about the money? A qualitative exploration of the effects of performance-based financial incentives on Zimbabwe's voluntary male medical circumcision program. PLoS One (2017) 0.75

Public stewardship of private for-profit healthcare providers in low- and middle-income countries. Cochrane Database Syst Rev (2016) 0.75

A mixed methods approach to evaluating community drug distributor performance in the control of neglected tropical diseases. Parasit Vectors (2016) 0.75

Performance-based incentives may be appropriate to address challenges to delivery of prevention of vertical transmission of HIV services in rural Mozambique: a qualitative investigation. Hum Resour Health (2016) 0.75

The inescapable question of fairness in Pay-for-performance bonus distribution: a qualitative study of health workers' experiences in Tanzania. Global Health (2016) 0.75

A qualitative study assessing the acceptability and adoption of implementing a results based financing intervention to improve maternal and neonatal health in Malawi. BMC Health Serv Res (2016) 0.75

Race to the Top: evaluation of a novel performance-based financing initiative to promote healthcare delivery in rural Rwanda. Glob Health Action (2016) 0.75

Exploring implementation practices in results-based financing: the case of the verification in Benin. BMC Health Serv Res (2017) 0.75

Out-of-pocket expenditure and its determinants in the context of private healthcare sector expansion in sub-Saharan Africa urban cities: evidence from household survey in Ouagadougou, Burkina Faso. BMC Res Notes (2016) 0.75

Taking stock: protocol for evaluating a family planning supply chain intervention in Senegal. Reprod Health (2016) 0.75

Understanding causal pathways within health systems policy evaluation through mediation analysis: an application to payment for performance (P4P) in Tanzania. Implement Sci (2017) 0.75

Targeting the poorest in a performance-based financing programme in northern Cameroon. Health Policy Plan (2016) 0.75

Effective health care for older people living and dying in care homes: a realist review. BMC Health Serv Res (2016) 0.75

Quality of Case Management for Pneumonia and Diarrhea Among Children Seen at Health Facilities in Southern Malawi. Am J Trop Med Hyg (2017) 0.75

Combining Theory-Driven Evaluation and Causal Loop Diagramming for Opening the 'Black Box' of an Intervention in the Health Sector: A Case of Performance-Based Financing in Western Uganda. Int J Environ Res Public Health (2017) 0.75

Payment methods for outpatient care facilities. Cochrane Database Syst Rev (2017) 0.75

Overcoming Health System Challenges for Women and Children Living With HIV Through the Global Plan. J Acquir Immune Defic Syndr (2017) 0.75

Articles by these authors

Use of evidence in WHO recommendations. Lancet (2007) 6.12

Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med (2007) 5.63

SUPPORT Tools for evidence-informed health Policymaking (STP). Health Res Policy Syst (2009) 3.93

The OFF theory of research utilization. J Clin Epidemiol (2005) 3.79

SUPPORT Tools for evidence-informed health Policymaking (STP) 14: Organising and using policy dialogues to support evidence-informed policymaking. Health Res Policy Syst (2009) 3.45

SUPPORT Tools for evidence-informed health Policymaking (STP) 13: Preparing and using policy briefs to support evidence-informed policymaking. Health Res Policy Syst (2009) 3.34

SUPPORT Tools for evidence-informed health Policymaking (STP) 1: What is evidence-informed policymaking? Health Res Policy Syst (2009) 3.32

Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst (2006) 3.31

Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement. Health Res Policy Syst (2006) 2.93

Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence. Health Res Policy Syst (2006) 2.29

Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol (2008) 2.28

Improving the use of research evidence in guideline development: 1. Guidelines for guidelines. Health Res Policy Syst (2006) 2.24

Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res (2012) 2.16

SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem. Health Res Policy Syst (2009) 2.15

SUPPORT Tools for evidence-informed health Policymaking (STP) 9: Assessing the applicability of the findings of a systematic review. Health Res Policy Syst (2009) 2.05

SUPPORT Tools for evidence-informed health Policymaking (STP) 10: Taking equity into consideration when assessing the findings of a systematic review. Health Res Policy Syst (2009) 2.03

SUPPORT tools for evidence-informed policymaking in health 11: Finding and using evidence about local conditions. Health Res Policy Syst (2009) 2.00

SUPPORT Tools for evidence-informed health Policymaking (STP) 7: Finding systematic reviews. Health Res Policy Syst (2009) 1.99

Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARA J (2008) 1.90

SUPPORT Tools for evidence-informed health Policymaking (STP) 8: Deciding how much confidence to place in a systematic review. Health Res Policy Syst (2009) 1.86

SUPPORT Tools for evidence-informed health Policymaking (STP) 3: Setting priorities for supporting evidence-informed policymaking. Health Res Policy Syst (2009) 1.84

SUPPORT Tools for evidence-informed health Policymaking (STP) 5: Using research evidence to frame options to address a problem. Health Res Policy Syst (2009) 1.82

Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines. Health Res Policy Syst (2007) 1.81

Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst (2006) 1.80

Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Res Policy Syst (2006) 1.80

Improving the use of research evidence in guideline development: 7. Deciding what evidence to include. Health Res Policy Syst (2006) 1.67

Improving the use of research evidence in guideline development: 2. Priority setting. Health Res Policy Syst (2006) 1.66

Improving the use of research evidence in guideline development: 16. Evaluation. Health Res Policy Syst (2006) 1.60

Can paying for results help to achieve the Millennium Development Goals? Overview of the effectiveness of results-based financing. J Evid Based Med (2009) 1.56

SUPPORT Tools for evidence-informed health Policymaking (STP) 2: Improving how your organisation supports the use of research evidence to inform policymaking. Health Res Policy Syst (2009) 1.54

Improving the use of research evidence in guideline development: 14. Reporting guidelines. Health Res Policy Syst (2006) 1.51

Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity. Health Res Policy Syst (2006) 1.46

[Thiazides (only) and hard endpoints]. Tidsskr Nor Laegeforen (2004) 1.39

SUPPORT Tools for evidence-informed health Policymaking (STP) 17: Dealing with insufficient research evidence. Health Res Policy Syst (2009) 1.37

SUPPORT Tools for evidence-informed health Policymaking (STP) 12: Finding and using research evidence about resource use and costs. Health Res Policy Syst (2009) 1.31

SUPPORT Tools for evidence-informed health Policymaking (STP) 16: Using research evidence in balancing the pros and cons of policies. Health Res Policy Syst (2009) 1.30

SUPPORT Tools for evidence-informed health Policymaking (STP) 15: Engaging the public in evidence-informed policymaking. Health Res Policy Syst (2009) 1.30

Improving the use of research evidence in guideline development: 6. Determining which outcomes are important. Health Res Policy Syst (2006) 1.27

Can paying for results help to achieve the Millennium Development Goals? A critical review of selected evaluations of results-based financing. J Evid Based Med (2009) 1.24

[Guidelines in general practice--are they read and are they used?]. Tidsskr Nor Laegeforen (2005) 1.21

Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev (2013) 1.17

Performance-based financing in low- and middle-income countries: still more questions than answers. Bull World Health Organ (2012) 1.16

The effect of alternative graphical displays used to present the benefits of antibiotics for sore throat on decisions about whether to seek treatment: a randomized trial. PLoS Med (2009) 1.09

The "Child Health Evidence Week" and GRADE grid may aid transparency in the deliberative process of guideline development. J Clin Epidemiol (2012) 1.05

Leadership and governance in seven developed health systems. Health Policy (2012) 0.95

The Patient-Reported Incident in Hospital Instrument (PRIH-I): assessments of data quality, test-retest reliability and hospital-level reliability. BMJ Qual Saf (2013) 0.91

Study-design selection criteria in systematic reviews of effectiveness of health systems interventions and reforms: A meta-review. Health Policy (2012) 0.88

Comparison of alternative evidence summary and presentation formats in clinical guideline development: a mixed-method study. PLoS One (2013) 0.88

Use of evidence in WHO recommendations. World Hosp Health Serv (2007) 0.86

The impact of demand factors, quality of care and access to facilities on contraceptive use in Tanzania. J Biosoc Sci (2005) 0.85

A televised, web-based randomised trial of an herbal remedy (valerian) for insomnia. PLoS One (2007) 0.84

Elevated plasma levels of the factor Xa-TFPI complex in cancer patients. Thromb Res (2002) 0.84

Guideline group composition and group processes: article 3 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc (2012) 0.83

[How do general practice assistants keep themselves up to date?]. Tidsskr Nor Laegeforen (2005) 0.81

How can research contribute to better global health? Tidsskr Nor Laegeforen (2011) 0.79

Prothrombotic activity is associated with the anatomical as well as the functional severity of peripheral arterial occlusive disease. Thromb Haemost (2006) 0.78

Barriers to skilled birth attendance: a survey among mothers in rural Gambia. Afr J Reprod Health (2014) 0.78

The effect of how outcomes are framed on decisions about whether to take antihypertensive medication: a randomized trial. PLoS One (2010) 0.78

[What do general practitioners do to keep themselves up to date?]. Tidsskr Nor Laegeforen (2005) 0.77

[Documented good enough?]. Tidsskr Nor Laegeforen (2010) 0.77

Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis. BMC Cardiovasc Disord (2012) 0.76

VALUE: analysis of results. Lancet (2004) 0.76

[A. Fretheim replies]. Tidsskr Nor Laegeforen (2013) 0.75

[Misleading about thiazides]. Tidsskr Nor Laegeforen (2004) 0.75

Current medical treatment for tuberculosis. More weight was given to observational studies than randomised controlled trials. BMJ (2003) 0.75

Does bullying lead to health problems? Tidsskr Nor Laegeforen (2014) 0.75

[Criticism of Norwegian screening study]. Tidsskr Nor Laegeforen (2008) 0.75

Tidsskr Nor Laegeforen (2017) 0.75

[More and better evaluations in health care]. Tidsskr Nor Laegeforen (2009) 0.75

[Do patients with vascular diseases receive sufficiently good care?]. Tidsskr Nor Laegeforen (2009) 0.75

[Beds for patients in palliative care at a surgery department]. Tidsskr Nor Laegeforen (2006) 0.75

[Drugs against the neglected diseases]. Tidsskr Nor Laegeforen (2002) 0.75

[Shortcomings and strength of practice guidelines]. Tidsskr Nor Laegeforen (2003) 0.75

WITHDRAWN: Group based diabetes self-management education compared to routine treatment, waiting list control or no intervention for people with type 2 diabetes mellitus. Cochrane Database Syst Rev (2015) 0.75

[Thiazides in the treatment of hypertension]. Tidsskr Nor Laegeforen (2003) 0.75

[Intermediate care beds at a surgery department]. Tidsskr Nor Laegeforen (2006) 0.75

[Most help to the needest]. Tidsskr Nor Laegeforen (2005) 0.75